BRITTANY LANICH: Open Payments
NPI 1255085361 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 81 payments from 16 companies in 2025. Trend: 2023 $497 · 2024 $711 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $256 |
| Novo Nordisk Inc | 17 | $202 |
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| GlaxoSmithKline, LLC. | 12 | $148 |
| PFIZER INC. | 5 | $79 |
| Exact Sciences Corporation | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Paratek Pharmaceuticals, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $37 |
Products named: AIRSUPRA, VRAYLAR, Ozempic, Wegovy, QULIPTA, NURTEC ODT, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
